Development of 18Flabeled compounds for imaging of Aβ plaques by means of PET

Behrooz Hooshyar Yousefi; Hans Jäurgen Wester

doi:10.2217/9781909453968.FSEB2013.13.73

Development of ¹⁸Flabeled compounds for imaging of Aβ plaques by means of PET

Behrooz Hooshyar Yousefi
, Hans Jäurgen Wester

Chair of Pharmaceutical Radiochemistry

University of Tabriz

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Currently, several 18F-labeled radiopharmaceuticals for -amyloid (A)-PET have become available and some of them have already been approved by the US FDA.

Original language	English
Title of host publication	Fluorinated Pharmaceuticals
Subtitle of host publication	Advances in Medicinal Chemistry
Publisher	Future Medicine Ltd.
Pages	78-92
Number of pages	15
ISBN (Electronic)	9781909453968
ISBN (Print)	9781910419007
DOIs	https://doi.org/10.2217/9781909453968.FSEB2013.13.73
State	Published - 1 Jul 2015

Access to Document

10.2217/9781909453968.FSEB2013.13.73

Cite this

@inbook{8aeb188a9e37435f860c3c19590f2ad3,

title = "Development of 18Flabeled compounds for imaging of Aβ plaques by means of PET",

abstract = "Currently, several 18F-labeled radiopharmaceuticals for -amyloid (A)-PET have become available and some of them have already been approved by the US FDA.",

author = "Yousefi, \{Behrooz Hooshyar\} and Wester, \{Hans J{\"a}urgen\}",

year = "2015",

month = jul,

day = "1",

doi = "10.2217/9781909453968.FSEB2013.13.73",

language = "English",

isbn = "9781910419007",

pages = "78--92",

booktitle = "Fluorinated Pharmaceuticals",

publisher = "Future Medicine Ltd.",

}

TY - CHAP

T1 - Development of 18Flabeled compounds for imaging of Aβ plaques by means of PET

AU - Yousefi, Behrooz Hooshyar

AU - Wester, Hans Jäurgen

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Currently, several 18F-labeled radiopharmaceuticals for -amyloid (A)-PET have become available and some of them have already been approved by the US FDA.

AB - Currently, several 18F-labeled radiopharmaceuticals for -amyloid (A)-PET have become available and some of them have already been approved by the US FDA.

UR - https://www.scopus.com/pages/publications/84957093312

U2 - 10.2217/9781909453968.FSEB2013.13.73

DO - 10.2217/9781909453968.FSEB2013.13.73

M3 - Chapter

AN - SCOPUS:84957093312

SN - 9781910419007

SP - 78

EP - 92

BT - Fluorinated Pharmaceuticals

PB - Future Medicine Ltd.

ER -

Development of ¹⁸Flabeled compounds for imaging of Aβ plaques by means of PET

Abstract

Access to Document

Other files and links

Fingerprint

Cite this